Eltivutabart is a humanized monoclonal antibody targeting ENTPD1/CD39. It increases extracellular ATP and reduces immunosuppressive adenosine, thereby promoting antitumor immunity. It is suitable for studying metastatic pancreatic cancer.
Clonality:
Monoclonal
Concentration:
6.47 mg/mL
Molecular Weight:
145.5
Purity:
95.00% (May vary between batches)
CAS Number:
[2935496-38-9]
Target:
Phosphatase
* VAT and and shipping costs not included. Errors and price changes excepted